APA (7th ed.) Citation

Velicki, L., Popovic, D., Okwose, N. C., Preveden, A., Tesic, M., Tafelmeier, M., . . . Miljkovic, T. (2024). Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM). European Journal of Heart Failure, 26(6), 1361. https://doi.org/10.1002/ejhf.3291

Chicago Style (17th ed.) Citation

Velicki, Lazar, et al. "Sacubitril/valsartan for the Treatment of Non‐obstructive Hypertrophic Cardiomyopathy: An Open Label Randomized Controlled Trial (SILICOFCM)." European Journal of Heart Failure 26, no. 6 (2024): 1361. https://doi.org/10.1002/ejhf.3291.

MLA (9th ed.) Citation

Velicki, Lazar, et al. "Sacubitril/valsartan for the Treatment of Non‐obstructive Hypertrophic Cardiomyopathy: An Open Label Randomized Controlled Trial (SILICOFCM)." European Journal of Heart Failure, vol. 26, no. 6, 2024, p. 1361, https://doi.org/10.1002/ejhf.3291.